** ASX-listed shares of Australia's AVITA Medical AVH.AX RCEL.O rise as much as 7.9% to A$4.11
** Stock set for strongest trading session since early Nov and hits highest since Dec. 12
** Co says U.S. Food and Drug Administration granted approval for its Recell Go mini product
** The product is a mini disposable cartridge designed to treat smaller wounds
** Stock had fallen 11.2% this year, as of last close
(Reporting by Rishav Chatterjee in Bengaluru)
((Rishav.Chatterjee@thomsonreuters.com;))